Using CRISPR/Cas technology to generate A549 human lung cancer subline with knockout of the E2F1 gene

М. А. Zamkova; D. B. Kazansky; V. V. Tatarskiy

Medical Genetics
Medicinskaâ genetika

ISSN 2073-7998 (Print)

User

eng | рус

Medical Genetics

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Zamkova М.А., Kazansky D.B., Tatarskiy V.V. Using CRISPR/Cas technology to generate A549 human lung cancer subline with knockout of the E2F1 gene. Medical Genetics. 2024;23(11):40-46. (In Russ.) https://doi.org/10.25557/2073-7998.2024.11.40-46

Views PDF (Rus): 25

JATS XML

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2073-7998 (Print)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

E.K. Ginter

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

М. А. Zamkova
Institute of Gene Biology, Russian Academy of Sciences; National Medical Research Center of Oncology named after N.N. Blokhin of the Ministry of Health of the Russian Federation
Russian Federation

34/5, Vavilova st., Moscow, 119334;

23, Kashirskoe shosse, Moscow, 115522

D. B. Kazansky
National Medical Research Center of Oncology named after N.N. Blokhin of the Ministry of Health of the Russian Federation
Russian Federation

23, Kashirskoe shosse, Moscow, 115522

V. V. Tatarskiy
Institute of Gene Biology, Russian Academy of Sciences
Russian Federation

34/5, Vavilova st., Moscow, 119334

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Medical Genetics

For citations:

Cookies policy